We performed Kaplan‒Meier survival analysis in our investigation of the combined effects of CLDN18.2 with tumour-infiltrating lymphocytes (TILs), PD-L1, HER2, or Foxp3 on the prognosis of gastric cancer (GC) (Fig. 5). This evidence concerns the gene ERBB2 and gastric cancer.